Literature DB >> 2460307

Recent advances in understanding the pharmacology of amiodarone.

S Nattel1, M Talajic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2460307     DOI： 10.2165/00003495-198836020-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  61 in total

1.  A comparison of plasma, white blood cell, red blood cell, and tissue distribution of amiodarone and desethylamiodarone in anesthetized dogs.

Authors:  S Bandyopadhyay; P Somani
Journal:  J Cardiovasc Pharmacol       Date:  1987-10       Impact factor: 3.105

2.  Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers.

Authors:  A Varro; Y Nakaya; V Elharrar; B Surawicz
Journal:  Eur J Pharmacol       Date:  1985-06-19       Impact factor: 4.432

3.  Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone.

Authors:  J W Mason; L M Hondeghem; B G Katzung
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

4.  Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region.

Authors:  H O Gloor; F Urthaler; T N James
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy.

Authors:  B N Singh; K Nademanee
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

6.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

7.  Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide.

Authors:  J Windle; E N Prystowsky; W M Miles; J J Heger
Journal:  Clin Pharmacol Ther       Date:  1987-06       Impact factor: 6.875

8.  Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias.

Authors:  K Nademanee; B N Singh; B Callahan; J A Hendrickson; J M Hershman
Journal:  Am J Cardiol       Date:  1986-11-01       Impact factor: 2.778

9.  Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.

Authors:  M L Greenberg; B B Lerman; J R Shipe; D L Kaiser; J P DiMarco
Journal:  J Am Coll Cardiol       Date:  1987-05       Impact factor: 24.094

10.  Efficacy of chronic amiodarone therapy in patients with variant angina pectoris and inhibition of ergonovine coronary constriction.

Authors:  B Rutitzky; A L Girotti; M B Rosenbaum
Journal:  Am Heart J       Date:  1982-01       Impact factor: 4.749
View more
  8 in total

Review 1.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

2.  Effects of amiodarone on cardiac function and mitochondrial oxidative phosphorylation during ischemia and reperfusion.

Authors:  D Moreau; F Clauw; L Martine; A Grynberg; L Rochette; L Demaison
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

3.  Dramatic inhibition of amiodarone metabolism induced by grapefruit juice.

Authors:  C C Libersa; S A Brique; K B Motte; J F Caron; L M Guédon-Moreau; L Humbert; A Vincent; P Devos; M A Lhermitte
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

Review 4.  Is there a future for antiarrhythmic drug therapy?

Authors:  P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

5.  Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.

Authors:  Gernot Schram; Liming Zhang; Katayoun Derakhchan; Joachim R Ehrlich; Luiz Belardinelli; Stanley Nattel
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

Review 6.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

Review 7.  The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.

Authors:  Jordi Heijman; Vincent Algalarrondo; Niels Voigt; Jonathan Melka; Xander H T Wehrens; Dobromir Dobrev; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2015-12-23       Impact factor: 10.787

Review 8.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.